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In recent years, many genomewide screens have been performed, to identify novel loci predisposing to various
complex diseases. Often, only a portion of the collected clinical data from the study subjects is used in the actual
analysis of the trait, and much of the phenotypic data is ignored. With proper consent, these data could subsequently
be used in studies of common quantitative traits influencing human biology, and such a reanalysis method would
be further justified by the nonbiased ascertainment of study individuals. To make our point, we report here a
quantitative-trait-locus (QTL) analysis of body-mass index (BMI) and stature (i.e., height), with genotypic data
from genome scans of five Finnish study groups. The combined study group was composed of 614 individuals
from 247 families. Five study groups were originally ascertained in genetic studies on hypertension, obesity, oste-
oarthritis, migraine, and familial combined hyperlipidemia. Most of the families are from the Finnish Twin Cohort,
which represents a population-wide sample. In each of the five genome scans, ∼350 evenly spaced markers were
genotyped on 22 autosomes. In analyzing the genotype data by a variance-component method, we found, on
chromosome 7pter (maximum multipoint LOD score of 2.91), evidence for QTLs affecting stature, and a second
locus, with suggestive evidence for linkage to stature, was detected on chromosome 9q (maximum multipoint LOD
score of 2.61). Encouragingly, the locus on chromosome 7 is supported by the data reported by Hirschhorn et al.
(in this issue), who used a similar method. We found no evidence for QTLs affecting BMI.
Introduction
The pedigrees collected for genome scans for complex
diseases are typically ascertained via probands who
manifest either clinically verified disease or extreme val-
ues for a quantitative risk factor. Multiple phenotypic
variables, including stature of and weight of study sub-
jects, are often either recorded as part of a basic medical
history or are determined by a routine physical exami-
nation. In statistical analysis, these traits are usually ig-
nored or incorporated either as covariates predictive of
the disease or as associated risk factors. Even though
these quantitative traits may not be clinically important
enough to warrant independent genome scans, they are
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often interesting for the understanding of human biology
and, as such, are worthy targets for quantitative-trait-
locus (QTL) mapping. In the mapping of QTLs for such
secondary traits, care must be taken to avoid ascertain-
ment biases; for instance, if the secondary trait is
strongly correlated with the original disease, naı¨ve anal-
ysis may lead to false-positive results (Go¨ring and Ter-
williger 2000). To a large extent, these biases can be
circumvented by (a) selecting those secondary traits that
are only weakly correlated with the disease or the risk
factor, (b) conditioning on the proband’s secondary
traits in analysis, and (c) pooling of study samples as-
certained for different diseases.
Body-mass index (BMI) and stature are good exam-
ples of quantitative traits with high heritability (Solo-
mon et al. 1983; Korkeila et al. 1991; Allison et al.
1996; Preece 1996; Silventoinen et al. 2000). Here we
use these traits in a proof-of-principle study using geno-
types produced in five separate genomewide scans orig-
inally performed for osteoarthritis (Leppa¨vuori et al.
1999), familial combined hyperlipidemia (FCHL) (Pa-
jukanta et al. 1999), hypertension (Perola et al. 2000),
obesity (O¨hman et al. 2000), and migraine (Wessman
et al. 1998). Two suggestive loci controlling height are
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Table 1
Demographic Characteristics of the Study Groups
STUDY
GROUP
NO. OF INDIVIDUALS
AGEa
(years)
BMI
(kg/m2)
STATURE
(cm)
Female Male Total Mean (SD) Range Mean (SD) Range Skewnessb Kurtosisb Mean (SD) Range Skewnessb Kurtosisb
Arthrosis 50 15 65 58.4 (11.4) 20–80 26.2 (4.2) 17.4–39.9 .37 .79 166.5 (7.8) 152–186 .56 .11
FCHL 78 63 141 47.5 (12.6) 20–76 37.2 (4.0) 17.4–37.2 .73 .62 168.2 (9.2) 148–191 .13 .64
Hypertension 68 34 102 56.1 (8.5) 39–74 25.5 (3.1) 18.6–33.5 .42 .29 166.1 (8.8) 150–186 .02 .60
Migraine 78 9 87 42.6 (7.1) 32–62 24.1 (3.8) 17.4–37.9 .25 .14 164.7 (5.8) 151–182 .48 .38
Obesity 122 63 185 49.9 (8.9) 21–72 36.7 (6.1) 22.3–56.6 .38 .37 166.2 (7.7) 144–194 .26 .14
All 396 184 580 50.4 (11.2) 20–80 29.4 (6.9) 17.4–56.6 .10 .41 166.5 (8.4) 144–194 .27 .25
NOTE.—Only nonfounder individuals for whom both genotypic and phenotypic data were available were included.
a Individuals !20 years of age were excluded.
b After corrections (i.e., substitution of square root of stature and reciprocal of BMI).
apparent from our data analysis, one of which overlaps
with a locus also identified by an independent study
(Hirschhorn et al. 2001 [in this issue]).
Subjects, Material, and Methods
Study Groups
The combined study group comprised 614 individuals
from 247 Finnish families. Most of the families analyzed
are from the Finnish Twin Cohort (Kaprio 1994). The
concordant DZ twin pairs were ascertained according to
explicit clinical criteria (Wessman et al. 1998; Leppa¨vuori
et al. 1999; O¨hman et al. 2000; Perola et al. 2000) The
families with FCHLwere chosen from the EuropeanMul-
ticenter Study on Familial Dyslipidemias (Pajukanta et al.
1997; Porkka et al. 1997) and are not from the Finnish
Twin Cohort. The probands in this study were patients
at Finnish University Hospitals who had been diagnosed
as having at-risk lipid profiles and premature coronary
heart disease (Pajukanta et al. 1997). The study groups
were supplemented by recruiting the probands’ available
parents and siblings. A more detailed description of the
patient selection is available elsewhere (Wessman et al.
1998; Leppa¨vuori et al. 1999; Pajukanta et al. 1999; O¨h-
man et al. 2000; Perola et al. 2000). This combined study
group included the following: from the osteoarthritis
study group, 94 individuals from 31 families; from the
obesity study group, 236 individuals from 87 families;
from the migraine study group, 108 individuals from 47
families; from the hypertension study group, 139 indi-
viduals from 47 families; and, from the FCHL study
group, 174 individuals from 35 families. The number of
nonfounders with phenotypic data (which produce the
most information for linkage) is given, for each project,
in table 1; individuals with no phenotypic data but with
genotypic data were included, for phase information.
Only 34 pedigree founders—all from the FCHL study
group—had phenotypic data.
All the study subjects from the Finnish Twin Cohort
Study have replied to queries about stature and weight,
in health questionnaires mailed in 1981, 1990, or later.
The nontwin family members were identified, and they
responded to the disease-specific questionnaires. In ad-
dition, participants in the obesity study group and par-
ticipants in the FCHL study group were clinically ex-
amined from 1990 onward. Of the individuals in the
study, 57% were measured, for stature and weight, in
clinical research centers; the remaining 43% were from
the Finnish Twin Cohort. The questionnaire method
used in the Finnish Twin Cohort Study has previously
been validated for both stature (Silventoinen et al. 2000)
and weight (Korkeila et al. 1991). The most recent re-
ported weight was used. All study participants provided
both informed consent to genetic studies of specific traits
and permission to access their health records. The blood
samples were bar coded on their arrival at the laboratory,
and personal information identifying patients and their
families was not made available to the investigators per-
forming the genetic studies.
Genotyping
DNAwas extracted fromEDTA-anticoagulatedwhole
blood according to standard procedures. In the five ge-
nome scans, ∼350 microsatellite markers—included in
the Weber screening set version 6 (Sheffield et al. 1995)
and spaced, on average, 10.0 cM apart—were genotyped
on 22 autosomes. The estimated average heterozygosity
for the markers was .76. The fluorescently labeled PCR
products were electrophoretically separated on an ABI
377XL automated DNA sequencer (Perkin Elmer), with
analysis by Applied Biosystems’ GENESCAN 2.1 soft-
ware (Perkin Elmer), or on an ALFexpress automated
laser-fluorescence DNA sequencer (Pharmacia Biotech).
Analysis and assignment of the marker alleles were per-
formed with GENOTYPER 2.0 (Perkin Elmer) or with
Allele Links (Pharmacia Biotech), by two persons in-
dependently for each marker. The genetic-map construc-
tion was based on the Marshfield linkage maps (Broman
et al. 1998). These baseline data were consistent both
with the maps used elsewhere (Wessman et al. 1998;
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Figure 1 LOD scores for QTLs for stature and BMI. The red
curve (computed by Solar 1.6.7) represents the multipoint LOD scores
for a QTL determining stature, and the blue curve represents the ge-
nomewide multipoint LOD score for a QTL determining BMI (both
are adjusted for age and for sex). The border of each autosome is
indicated by dotted lines.
Leppa¨vuori et al. 1999; Pajukanta et al. 1999; O¨hman
et al. 2000; Perola et al. 2000) and with our ownmarker-
to-marker linkage data in the families.
Statistical Analysis
Preliminary statistical analysis of the genotypes was
performed by SAS 8.01 (SAS Institute). BMI was defined
as weight/(height)2. In the combined study group, stature
and BMI were not normally distributed. Because QTL
mapping relies on normality, we replaced stature with its
square root and replaced BMI with its reciprocal. For
purposes of covariate adjustment, the study participants’
ages computed were those when their stature and weight
were recorded or measured. Genotyped markers were
checked for incompatibilities, by the programs PedCheck
(O’Connell and Weeks 1998) and MENDEL (Lange et
al. 1988). Most Mendelian errors could be resolved un-
ambiguously; the remaining errors were handled by ex-
cluding from linkage analysis, at all markers, the families
with errors. QTLmappingwas done by the programSolar
1.6.7 (Almasy and Blangero 1998), which incorporates
the variance-component program FISHER (Lange et al.
1988). Since subjects from the obesity study group who
had BMI30.0 kg/m2 and subjects from the hypertension
study group who had BMI !27.0 kg/m2 were originally
selected according to their BMI, they were, for ascertain-
ment correction, labeled as probands in the Solar analyses.
Because some markers were used in only a subset of the
scans, in the present study we omit the two-point LOD
scores and present only multipoint LOD scores. The list
of markers genotyped in each study group is given at our
website, Additional Tables for the Study. To determine
which study groups contributed most to identification of
loci, each study group was analyzed again, after the pri-
mary analyses for both phenotypes.
Results
The mean age of the 580 individuals genotyped in the
five genome scans was 50.4 years (SD 11.2) (table 1).
Females were 68% of the study group, and males were
32% of the study group. Although the stature and
weight of individuals !20 years of age were excluded
from the QTL analysis, the genotypes of these individ-
uals were retained to help to determine the genotypes
and the linkage phases of older family members, as were
the genotypes of all other persons with genotypic data
in the pedigrees. The full results of the QTL analyses
are given at our website, Additional Tables for the Study.
BMI
The BMIs of females and males in the combined study
group were 28.9 kg/m2 (SD 6.9) and 29.9 kg/m2 (SD
6.4), respectively. Given the inclusion of participants
from the obesity study group, it is hardly surprising that
analysis of variance shows a significant BMI difference
among the study groups ( ). The heritability ofP ! .0001
BMI in the combined study group was .55 (standard
error [SE] .09). BMI values were adjusted for age and
for sex, in the final model, by regressing age against sex
and then transforming to z scores, separately, for each
sex, by calculating the number of SD above or below
the mean. The highest multipoint LOD score for BMI,
1.29, was found on chromosome 5, 34 cM from the pter
(fig. 1). To control for ascertainment bias, we also an-
alyzed the study group without including genotypes col-
lected in the obesity group’s scan. The highest LOD
score, 1.04, was again found on chromosome 5, 23 cM
from pter. The multipoint LOD scores for BMI are given
at our website, Additional Tables for the Study. On the
basis of variance-component analysis, variation in the
chromosome 1 region would account for 36% of the
variation in BMI, with a residual additive genetic com-
ponent of 21% and with a random environmental con-
tribution of 43% (Comuzzie et al. 1997; Almasy and
Blangero 1998). When the study groups were analyzed
separately, a LOD score of 2.05, for the migraine study
group, was found on chromosome 5; therefore, this
group has the greatest contribution to this positive result.
Stature
The mean statures of females and of males in the com-
bined study group were 162.3 cm (SD 6.0) and 175.0 cm
(SD 6.1) (table 1), respectively. Analysis of variance did
not show a significant stature difference between the five
study groups ( ). The heritability of stature in thePp .14
combined study group was .69 (SE .08). Sex ( )P ! .0001
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Figure 2 LOD scores for QTLs for stature and BMI: chromosome 7. The blue curve expands the genomewide multipoint-LOD-score
curves in figure 1, to chromosome 7 alone. For comparison, the pink curve represents the results reported by Hirschhorn et al. (2001 [in this
issue]) for their Swedish study group, as discussed in the text. The numbers below the horizontal axis indicate distance (in cM) from 7pter.
and age ( ) were significantly correlated withPp .0002
stature and, thus, were included in the final analytical
model in QTL analysis. Stature had an inverse correlation
with age, for both sexes. The stature data were adjusted
by regressing stature against age, for each sex separately.
These age-corrected square roots of stature were then
transformed to z scores by calculating the number of SDs
above or below the mean. Figure 1 plots the multipoint
LOD scores computed by Solar 1.6.7. Multipoint LOD
scores for individual chromosomes can be viewed at our
website, Additional Tables for the Study. The highestmul-
tipoint LOD score for stature, 2.91, was found on chro-
mosome 7, 164 cM from the pter (fig. 2). Another sug-
gestive LOD score, 2.61, was found on chromosome 9,
159 cM from the 9pter (fig. 3). According to variance-
component analysis, variation in the chromosome 7 re-
gion would account for 34% and 33% of the variation
in stature, in the linked regions on chromosomes 7 and
9, respectively, with a residual additive genetic component
of 14% and with a random environmental contribution
of 19%.When the study groups were analyzed separately,
a multipoint LOD score of 2.3, for the hypertension study
group, was found on chromosome 7; therefore, this group
has the greatest contribution to this positive result. In
figures 1 and 2, we have also indicated the multipoint
findings that Hirschhorn et al. (2001 [in this issue]) have
reported for these chromosomes, to facilitate comparison
between the study groups.
Genomewide P Values
To assess the relative significance of our results, we
permuted age- and sex-corrected phenotypes and recal-
culated the multipoint LOD scores by using these per-
muted phenotypes. The adjustments, for age and sex co-
variates, that were used in the permuted scans were the
same as those used in the original data analysis. Phenotype
permutation was confined to the siblings within each fam-
ily. Since not all individuals were genotyped for all mark-
ers, the phenotypes, rather than the genotypes, were per-
muted. In our 100 permuted genome scans, we found the
maximummultipoint LOD score,2.91, 14 times, which
results in an empiric P value of .14. LOD scores 2.61
were seen 32 times ( ). Only four of these per-Pp .32
muted genome scans showed a combination of two or
more LOD scores that were 12.61 ( ).Pp .04
Discussion
Once panels of evenly distributed, informative markers
became available for genomewide scans, the search for
genes predisposing to complex diseases commencedwith
great enthusiasm. Unfortunately, few real successes in
gene identification have yet been reported (Weiss and
Terwilliger 2000). One explanation for these failures is
the information loss that occurs when quantitative com-
plex traits are dichotomized, according to accepted di-
agnostic criteria, into yes/no disease states. With the ad-
Perola et al.: QTL Analysis of BMI and Stature 121
Figure 3 LOD scores for QTLs for stature and BMI: chromosome 9. The blue curve expands the genomewide multipoint-LOD-score
curves in figure 1, to chromosome 9 alone. For comparison, the pink curve represents the results reported by Hirschhorn et al. (2001 [in this
issue]) for their Botnian study group, as discussed in the text. The numbers below the horizontal axis indicate distance (in cM) from 9pter.
vent of more-advanced QTL-mapping methods (Almasy
and Blangero 1998), there is now no excuse for wasting
the precious quantitative information collected via these
scans. Similarly, most of the routine phenotypic and clin-
ical data collected in genetic studies are not used in the
subsequent analyses. Typically, the disease traits are an-
alyzed, and most of the ancillary data are disregarded.
Clearly, exploiting the secondary traits should not be
allowed if study participants have not provided informed
consent for genetic analysis of all phenotypic data. If,
however, proper, informed consent has been given, use
of all the available phenotypic data has a tremendous
potential to expose important features of biological var-
iation. The present study has conducted the kind of
meta-analysis commonly employed in epidemiology.
Our analysis of QTLs of BMI and of stature combines
information from five genomewide scans performed in
Finland. The selected variables analyzedwere stature (i.e.,
height) and relative weight (i.e., BMI). In our combined
study group of 614 individuals, we found suggestive ev-
idence for linkage between stature and a QTL on chro-
mosome 7q. This intriguing result is consistent with the
linkage peak reported by Hirschhorn et al. (2001 [in this
issue]) for a Swedish study group. The two peaks on this
chromosome that were reported by these two studies are
remarkably close. Unfortunately, neither the pedigrees
from western Finland (specifically, Botnia) nor the ped-
igrees from Helsinki, in southern Finland, provide much
evidence for linkage to this 7qter region, in the study by
Hirschhorn et al. (2001 [in this issue]). Our strategy is
somewhat different from that of Hirschhorn et al. (2001
[in this issue]); whereas they analyzed their scans sepa-
rately, we combined the raw data of five scans and an-
alyzed the geno- and phenotypes together. Also, all the
scans in our study were ascertained for different phe-
notypes, and, although most study groups ascertained
are from the genetically isolated Finland, the contribution
of subisolates varies greatly and can have an effect on
contribution of different loci (Kittles et al. 1998). The
two study groups with matching linkage peaks on this
chromosome 7 region are among the largest in these two
studies, indicating the real significance of this locus. An-
other region that, in our study, showed some evidence
for linkage, on chromosome 9, was not replicated as
successfully by Hirschhorn et al. (2001 [in this issue]);
however, in the analysis of complex traits, the peak points
for the same gene locus can widely vary between different
studies (Terwilliger and Go¨ring 2000). The intervals sup-
porting linkage to stature QTLs on chromosomes 7 and
9 remain quite wide, and, thus, it is not relevant to list
any obvious positional candidate genes, at this stage. We
did not see any evidence for linkage to chromosome 20,
where a previous linkage for stature has been reported
(Thompson et al. 1995).
The suggestive area for a dichotomized phenotype
(i.e., obesity) reported, elsewhere (O¨hman et al. 2000),
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in a group from the present study, was not replicated
in the present study. Also, we found no peaks in the
regions reported in several genomewide scans for dif-
ferent variants of weight (Comuzzie et al. 1997; Hager
et al. 1998; Hanson et al. 1998; Lee et al. 1999). A
previous candidate-gene study (Mitchell et al. 1999) in
a population similar to that in the present study (i.e.,
one comprising mostly individuals not ascertained for
obesity) linked BMI to chromosome 8. We could not
replicate this finding. As a quantitative trait, BMI is
preferred to weight, because stature affects weight non-
linearly. BMI serves as an economic surrogate for rel-
ative obesity. Our positive evidence for two QTLs af-
fecting stature in our combined study group is not
balanced by equally convincing evidence for QTLs af-
fecting BMI. It is possible that this divergence reflects
the heritability difference (i.e., .70 vs. .55) between these
two traits. The adult stature of individuals is usually
attained during puberty and remains essentially the
same throughout adulthood, whereas adult BMI may
fluctuate considerably throughout adulthood. The nu-
merous environmental factors affecting adult BMI levels
make a single measurement of weight a less reliable
indicator of genetic influence than is a single measure-
ment of stature. Although genes affecting BMI doubtless
exist, the study groups—or pedigrees—necessary for de-
tection of a QTL for BMI may be significantly larger
than the combined study group assembled here.
The stature heritability found in our data closely
matches the heritabilities—.77 (95% confidence inter-
val [95%CI] .73–.82) among Finnish men and .76
(95%CI .71–.80) among Finnish women—reported by
Silventoinen et al. (2000). This consistency suggests that
nonadditive genetic influences on stature are rather
small, if present at all. The heritability difference be-
tween stature and BMI may partially explain why link-
age to stature but not to BMI was detected. It is inter-
esting that familial risk ratios for extreme obesity tend
to be higher than familial risk ratios for moderate obe-
sity (Allison et al. 1996; Lee et al. 1997).
To summarize, by combining collected genotypic data
from previously performed genomewide scans for com-
plex disease loci, we found, on chromosome 7, evidence
for a QTL determining stature, in agreement with the
results reported byHirschhorn et al. (2001 [in this issue]),
who used a similar analytical strategy. We also found,
on chromosome 9, some evidence for QTLs affecting
stature. Our results demonstrate that reanalyses of ge-
nome-scan data for common QTLs of variant traits can
expose influencing loci. Data mining and meta-analysis
of genotypes accumulated in numerous genome scans
worldwide would be extremely useful in the mapping of
many common traits and would increase the scientific
value of these expensive endeavors. Pooled data analyses
of representative study groups from different populations
would be highly beneficial, not only for the pursuit of
potential differences among populations but also for ef-
ficient restriction of the critical DNA regions of the QTL
loci and for final gene identification. Potentially, this strat-
egy could lead to the final identification of genes, so far
successfully cloned only in plants (Frary et al. 2000).
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